Skip to main content
Markdown filings API. Get API access →
OICS v0.3.3 class · Healthcare

Clinical-Stage Biotech

ID CLB HC.PH.BIO.CLB

Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.

Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.

Sector
HC Healthcare in the standard Medicines, medical technology and the delivery of care.
Group
HC.PH Medicines & Life Sciences Developing and making medicines, and the tools and services for it.
Industry
HC.PH.BIO Biotechnology in the standard Biology-based drug developers.

Companies whose primary class this is. The sector and industry pages and the screener count them the same way.

Counted by primary class: companies that are listed and have filings on FinancialFilings.

Company Ticker Country Market cap Filings
TISSUE REPAIR LTD TRP Australia — 150
Oncocross Co.,Ltd. 382150 South Korea — 148
TYK Medicines, Inc 2410 Hong Kong — 147
Cytophage Technologies Ltd. CYTO Canada — 146
ROKIT HEALTHCARE Inc. 376900 South Korea — 145
Beijing Luzhu Biotechnology Co., Ltd. 2480 Hong Kong — 144
Future Medicine Co., Ltd. 341170 South Korea — 142
Neural Therapeutics Inc. NURL Canada — 141
TAIWAN BIO THERAPEUTICS INC. 6892 Taiwan — 140
Abera Bioscience AB ABERA Sweden — 139
Orum Therapeutics, Inc. 475830 South Korea — 139
Andros Pharmaceuticals Co.,Ltd 6917 Taiwan — 135
Evommune, Inc. EVMN United States of America — 133
Hanx Biopharmaceuticals (Wuhan) Co., Ltd. 3378 Hong Kong — 127
IMGT Corporation Limited 456570 South Korea — 127
G2GBIO, Inc. 456160 South Korea — 125
Beijing Biostar Pharmaceuticals Co., Ltd. 2563 Hong Kong — 121
Heartseed Inc. 219A Japan — 120
Nanjing Leads Biolabs Co., Ltd. 9887 Hong Kong — 119
HighTide Therapeutics, Inc. 2511 Hong Kong — 117
PRISM BioLab Co.,LTD 206A Japan — 117
PROTEINA CO.,LTD. 468530 South Korea — 117
Pharos iBio Co., Ltd. 388870 South Korea — 116
HanchorBio Inc. 7827 Taiwan — 113
ME Therapeutics Holdings Inc. METX Canada — 108
Aladdin Healthcare Technologies SE NMI Germany — 105
BEBETTER MED INC. 688759 China — 105
Acepodia, Inc. 6976 Taiwan — 103
Incanthera plc INC United Kingdom — 103
Steminent Biotherapeutics Inc. 7729 Taiwan — 103
VISEN Pharmaceuticals 2561 Cayman Islands — 103
Duality Biotherapeutics, Inc. 9606 Cayman Islands — 102
Noile-Immune Biotech Inc. 4893 Japan — 101
Sunho Biologics, Inc. 2898 Hong Kong — 101
Atrium Therapeutics, Inc. RNA United States of America — 100
Cloudbreak Pharma Inc. 2592 Hong Kong — 100
Oncodesign Precision Medicine S.A ALOPM France — 97
GenFleet Therapeutics (Shanghai) Inc. 2595 Hong Kong — 95
Avant Technologies Inc. — United States of America — 93
InSilico Medicine Cayman TopCo 3696 Cayman Islands — 88
IntoCell, Inc. 287840 South Korea — 86
Veradermics, Inc MANE United States of America — 86
PegBio Co., Ltd. 2565 Hong Kong — 85
ImmuneOncia Therapeutics, Inc. 424870 South Korea — 84
Cellbion Co., Ltd 308430 South Korea — 83
Shine-On BioMedical Co., Ltd. 6926 Taiwan — 79
イノバセル株式会社 504A Japan — 78
First Tracks Biotherapeutics, Inc. TRAX United States of America — 77
ORGANOIDSCIENCES LTD. 476040 South Korea — 77
Pentixapharm Holding AG PTP Germany — 77

Companies in Biotechnology → Open in the screener →

Other names for this activity, and where neighboring activities go instead.

Also known as

preclinicaldrug developer

Not here
Commercial Biotech CMB HC.PH.BIO.CMB

Research-led company whose approved medicines, which it discovered, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more.

https://financialfilings.com/oics/CLB/

This page is keyed by the class ID CLB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.

See it in the full standard Download the standard